These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 557373)

  • 1. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. I. Culture conditions resulting in augmented cell-mediated cytotoxicity.
    Golub SH
    Cell Immunol; 1977 Feb; 28(2):371-8. PubMed ID: 557373
    [No Abstract]   [Full Text] [Related]  

  • 2. In vitro sensitization of human lymphoid cells to antigens on cultured melanoma cells. II. Sensitization against melanoma-associated antigens.
    Golub SH
    Cell Immunol; 1977 Feb; 28(2):379-89. PubMed ID: 849604
    [No Abstract]   [Full Text] [Related]  

  • 3. Human tumor cells grown in fetal calf serum and human serum: influences on the tests for lymphocyte cytotoxicity, serum blocking and serum arming effects.
    Sulit HL; Golub SH; Irie RF; Gupta RK; Grooms GA; Morton DL
    Int J Cancer; 1976 Apr; 17(4):461-8. PubMed ID: 945229
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Selective and non-selective lymphocytotoxicity in human melanoma: observation on the effect of long-term culture and fetal bovine serum on target-cell sensitivity to lymphocytes.
    Mukherji B; Vassos D; Flowers A; Binder SC; Nathanson L
    Int J Cancer; 1975 Dec; 16(6):971-80. PubMed ID: 53212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Specificity of antitumor immune reactions mediated by xenogeneic immune RNA.
    Kern DH; Drogemuller CR; Chow N; Holleman DD; Pilch YH
    J Natl Cancer Inst; 1977 Jan; 58(1):117-21. PubMed ID: 833854
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cytotoxic lymphocytes in melanoma patients.
    Faucault JP; Bernard JP; Potier JC; Lecacheux C
    Int J Cancer; 1972 May; 9(3):567-76. PubMed ID: 4676747
    [No Abstract]   [Full Text] [Related]  

  • 7. Sensitisation of lymphocytes in vitro against human melanoma-associated antigens.
    Golub SH; Morton DL
    Nature; 1974 Sep; 251(5471):161-3. PubMed ID: 4421563
    [No Abstract]   [Full Text] [Related]  

  • 8. Cell-mediated and serum blocking reactivity to tumor antigens in patients with malignant melanoma.
    Heppner GH; Stolbach L; Byrne M; Cummings FJ; McDonough E; Calabresi P
    Int J Cancer; 1973 Mar; 11(2):245-60. PubMed ID: 4790694
    [No Abstract]   [Full Text] [Related]  

  • 9. Lymphocyte activation in vitro to murine onco-foetal antigens.
    Chism S; Burton R; Warner NL
    Nature; 1975 Oct; 257(5527):594-6. PubMed ID: 52121
    [No Abstract]   [Full Text] [Related]  

  • 10. Cellular and humoral immunity against human malignant melanoma.
    Fossati G; Colnaghi MI; Porta GD; Cascinelli N; Veronesi U
    Int J Cancer; 1971 Sep; 8(2):344-50. PubMed ID: 4943925
    [No Abstract]   [Full Text] [Related]  

  • 11. Induction of cytotoxic activity in human lymphocytes against autologous and allogeneic melanoma cells in vitro by culture with interleukin 2.
    Hersey P; Bindon C; Edwards A; Murray E; Phillips G; McCarthy WH
    Int J Cancer; 1981 Dec; 28(6):695-703. PubMed ID: 6977498
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Blocking of cellular cytotoxicity by serum factors in progressive malignant melanoma].
    Saal JG; Rieber EP; Hadam M; Riethmüller G; Ehinger H; Wilms K; Wilmanns W
    Verh Dtsch Ges Inn Med; 1977 Apr 17-21; 83():1217-9. PubMed ID: 611821
    [No Abstract]   [Full Text] [Related]  

  • 13. Inhibition of lymphocyte cytotoxicity for human colon carcinoma by treatment with solubilized tumour membrane fractions.
    Baldwin RW; Embleton MJ; Price MR
    Int J Cancer; 1973 Jul; 12(1):84-92. PubMed ID: 4790711
    [No Abstract]   [Full Text] [Related]  

  • 14. Cytotoxicity of lymphocytes from healthy subjects and from melanoma patients against cultured melanoma cells.
    Pavie-Fischer J; Kourilsky FM; Picard F; Banzet P; Puissant A
    Clin Exp Immunol; 1975 Sep; 21(3):430-41. PubMed ID: 1204255
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A simple microassay for detection of antibodies to fetal calf serum and related antigens and its application to the serological definition of human tumor antigens.
    Liao SK; Rahman AF; Kwong PC; Dent PB
    J Immunol Methods; 1979; 27(2):111-25. PubMed ID: 110885
    [No Abstract]   [Full Text] [Related]  

  • 16. Cellular immunity to a common human sarcoma antigen and its specific inhibition by sera from patients with growing sarcomas.
    Cohen AM; Ketcham AS; Morton DL
    Surgery; 1972 Oct; 72(4):560-7. PubMed ID: 4506654
    [No Abstract]   [Full Text] [Related]  

  • 17. Cytotoxicity responses to melanoma cells by human lymphoid cell subpopulations.
    O'Neill PA; Mackler BF; Romsdahl MM
    J Natl Cancer Inst; 1976 Aug; 57(2):431-4. PubMed ID: 1087348
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytotoxic antibodies to cultured melanoma cells in the sera of melanoma patients.
    Ferrone S; Pellegrino MA
    J Natl Cancer Inst; 1977 May; 58(5):1201-4. PubMed ID: 67208
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immunity to human tumor-associated antigens. A review.
    Herberman RB
    Isr J Med Sci; 1973 Mar; 9(3):300-7. PubMed ID: 4575654
    [No Abstract]   [Full Text] [Related]  

  • 20. Mediation of cytotoxic immune responses against human tumor-associated antigens by allogeneic immune RNA.
    Kern DH; Fritze D; Schick PM; Chow N; Pilch YH
    J Natl Cancer Inst; 1976 Jul; 57(1):105-9. PubMed ID: 1003493
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.